Effects on adiposity-related biomarkers and nutrient intake status on metabolic syndrome
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patient Group: 100 adults over 20, who are diagnosed with metabolic syndrome
Control Group: 100 adults over 20, who has no evidence of insulin resistant or other metabolic syndrome
Exclusion Criteria
None of the participants had been diagnosed with cardiovascular disease, hypertension, diabetes, infectious diseases, diseases of the liver, thyroid or kidney, malignancy, acromegaly, Cushing syndrome, or any other serious medical problems. Volunteers who were taking systemic glucocorticoids, blood glucose lowering medications (eg, metformin, thiazolidinediones), anti-inflammatory medications, and immunosuppressant drugs were also excluded.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adipokines(Leptin, Adiponectin, Resistin), inflammatory cytokine(CRP, IL-6, CAMs, TNF-a, MCP-1)
- Secondary Outcome Measures
Name Time Method nutrient intake